UK’s NHS rolls out mirvetuximab soravtansine for hundreds of women with ovarian cancer
Supporting oncology professionals through education
The content on this site is intended for healthcare professionals only
The content on this site is intended for healthcare professionals only
UK’s NHS rolls out mirvetuximab soravtansine for hundreds of women with ovarian cancer
Researchers combine bacteria and viruses to demonstrate a new way to fight cancer
New CAR T treatment opens doors for patients in need of kidney transplant
Oral drug combination eases treatment burden for AML patients
New theranostic approach effectively detects and treats neuroendocrine prostate cancer
Can taking aspirin uncover asymptomatic bladder cancer?
ASCO 2026: Sacituzumab govitecan with pembrolizumab extends PFS for some metastatic triple-negative breast cancer patients
AI helps accelerate breast cancer diagnosis for high-risk women
ASCO 2026: Cancer vaccine sustains 49 percent melanoma reduction after 5 years
Dual PET imaging detects tumor progression and heart inflammation during cancer treatment
PSMA PET reveals bone metastases missed by standard imaging
ASCO 2026: EMERALD-3 study shows that new combination treatment strategies for embolization-eligible hepatocellular carcinoma are superior